News - Marketing authorisation medicines for human use

34 news items Marketing authorisation medicines for human use

Enter search criteria

Fill in keyword(s) to narrow your search.

Period from

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

Sort by: Date / Relevance

Subscribe to news from this organisation

DCP time slot tool temporarily switched off

Due to security precautions, the MEB has had to switch off the DCP time slot planning tool.

News item | 21-12-2020 | 10:00

Year-end withdrawals medicines for human use

Requests to withdraw marketing authorisations and parallel import marketing authorisations as of 31 December 2020, the so-called ...

News item | 01-09-2020 | 09:00

Implementation of the Medical Device Regulation postponed until 26 May 2021

Due to the coronavirus crisis the European Commission has postponed the implementation of the new Medical Device Regulation (MDR, ...

News item | 08-05-2020 | 17:00

MEB Portal shut down permanently

For safety reasons, the MEB portal was provisionally taken offline in January this year. Unfortunately, the MEB has had to take ...

News item | 20-04-2020 | 12:00

Request to take over the Fucidin marketing authorisation

The company Leo Pharma B.V. has informed the Medicines Evaluation Board (MEB) that the production of the antibiotic Fucidin ...

News item | 31-03-2020 | 17:00

Request to take over the pyridoxine hydrochloride marketing authorisation

The company Pharmachemie B.V. has requested the Medicines Evaluation Board (MEB) to withdraw marketing authorisation for ...

News item | 30-03-2020 | 17:00

Changes to product information policy

The Medicines Evaluation Board (MEB) recently revised a number of policy documents for pharmaceutical companies relating to the ...

News item | 23-03-2020 | 12:00

Amended policy on DHPCs

The Medicines Evaluation Board (MEB) has amended its policy on Direct Healthcare Professional Communications (DHPCs). This ...

News item | 21-02-2020 | 12:00

Shorter timetable for procedure for changing parallel package leaflet

The Medicines Evaluation Board (MEB) has decided to implement a shorter timetable for the procedure for changing the parallel ...

News item | 30-12-2019 | 08:38

MEB fee rate change as of January 2020

The Medicines Evaluation Board (MEB) is increasing the fee rates for authorisation applications, authorisation changes and the ...

News item | 24-12-2019 | 12:00